Actoplus Met

Actoplus Met
Analogs:
Metformin Pioglitazone Janumet Jentadueto Synjardy Invokamet Januvia Jardiance Farxiga Invokana Ozempic Rybelsus Trulicity Amaryl Competact Avandamet Xigduo Kombiglyze Glucovance Metaglip Actos Glucophage
  • Buy Actoplus Met online with UK delivery; we do not require a prescription upload at checkout.
  • Combines metformin and pioglitazone to help manage blood glucose in adults with type 2 diabetes when metformin alone is not enough.
  • Supplied as 15 mg+500 mg tablets and taken with meals to reduce stomach upset.
  • Take it only as directed and at consistent times as part of your established diabetes treatment plan.
  • The blood-glucose-lowering effect of the pioglitazone component may take several weeks to develop fully.
  • It is unsuitable for people with heart failure or current or previous bladder cancer; liver and kidney function must also be assessed.
  • Fluid retention and ankle swelling can occur and should be reported promptly.
  • It should not be used during pregnancy or breastfeeding.
  • Could this combination tablet fit into your established diabetes routine?
In stock: 18 packs
AdultsPregnancyAllergiesBreastfeedingChildrenDriving

Dosages

Actoplus Met 15mg+500mg

Quantity Price per tablet You save Total price
30 £2.30 - £68.89
60 £1.88 £25.19 £112.60
90 £1.74 £50.37 £156.31
120 £1.67 £75.56 £200.02
180 £1.59 £126.68 £286.69
270 £1.55 £201.50 £418.55
360 £1.53 £277.06 £549.67

Manufacturers

Lupin LimitedTakeda Ireland LimitedTakeda Pharmaceutical Company LimitedUSV Private Limited

Payment & Delivery

Package Example

Your order is securely packed and usually dispatched within 24 hours. Here is what a typical parcel looks like.

It is about the size of a regular letter (24x11x0.7 cm) and does not show any details of what is inside.

Front View
Front View
Side View
Side View
Back View
Back View
Delivery Times
Delivery MethodEstimated delivery
Express Free for orders over £222.24Estimated delivery to the UK: 4-7 days
Standard Free for orders over £148.16Estimated delivery to the UK: 14-21 days
EMSRoyal Mail
Payment Methods
VisaMastercardAmerican ExpressJCBBitcoin, USDTApple PayGoogle PayPayPalKlarnaClearpay

Discount Coupons

  • New Year's Day - 1 January 2026 9% NEWYEAR9
  • Valentine's Day - 14 February 2026 6% VALENTINE6
  • St David's Day - 1 March 2026 4% DAVID4
  • St Patrick's Day - 17 March 2026 5% PATRICK5
  • St George's Day - 23 April 2026 4% GEORGE4
  • May Day - 1 May 2026 5% MAYDAY5
  • Halloween - 31 October 2026 6% HALLOWEEN6
  • Guy Fawkes Night - 5 November 2026 5% GUY5
  • Christmas Eve - 24 December 2026 9% XMASEVE9
  • Christmas Day - 25 December 2026 10% XMAS10
  • Boxing Day - 26 December 2026 10% BOXING10
  • New Year's Eve - 31 December 2026 8% NYE8

Brand Names

Also known as (by country):
CountryBrand Names
United Kingdom
Competact

FAQ

Do not take the tablets if the label does not show metformin and pioglitazone 15 mg/500 mg as expected. Keep the package available and have the active ingredients, strength, dosage form, manufacturer, lot number and expiry date checked before use.

This metformin and pioglitazone combination should not be used during pregnancy; diabetes treatment should be reviewed promptly if pregnancy is planned or confirmed. It should also be avoided while breastfeeding because metformin passes into breast milk and there are insufficient human data for pioglitazone.

Description

Actoplus Met at a Glance for UK Customers

Actoplus Met combines metformin and pioglitazone in a single tablet for adults with type 2 diabetes whose blood glucose remains inadequately controlled on metformin alone. Customers across England, Scotland, Wales, and Northern Ireland can buy Actoplus Met online through our pharmacy, with Express or Standard delivery and card or cryptocurrency payment options. We do not require a prescription upload at checkout, although anyone starting or changing diabetes treatment should first obtain appropriate clinical advice.

What Actoplus Met Means for UK Patients

Actoplus Met is a US catalogue brand, and many UK patients will be more familiar with metformin and pioglitazone prescribed separately or dispensed under their generic names through NHS clinics and community pharmacies. Diabetes teams may combine glucose-lowering medicines when one medicine no longer keeps blood glucose within an agreed target. For patients already established on this metformin-and-pioglitazone combination, perhaps after living or travelling abroad, recognising the Actoplus Met name can make it easier to identify a familiar treatment. However, the exact strength must always be checked because UK and overseas presentations are not necessarily interchangeable.

Everyday Use and Best Practices

Actoplus Met is used as part of a broader type 2 diabetes routine that may include dietary changes, regular activity, blood glucose monitoring, and scheduled clinical reviews. Taking the tablet at consistent times and swallowing it with a drink of water can make the routine easier to remember. Many people find it useful to associate each dose with a regular meal rather than treating it as a separate task. If a dose is missed, it should not be doubled; the next dose is taken at the usual time unless a prescriber has provided different instructions. Regular HbA1c checks arranged through a GP surgery or diabetes clinic help determine whether treatment is controlling blood glucose as intended.

Timing: Fitting Doses Around a UK Daily Routine

Because Actoplus Met contains metformin, it is taken with meals to improve gastrointestinal tolerability. The exact schedule should follow the directions provided for the individual patient rather than a general morning-or-evening rule. Breakfast or the main evening meal can provide a useful routine, depending on the prescribed schedule. For people working shifts in healthcare, retail, manufacturing, hospitality, or transport, linking treatment to consistent meals may be more practical than relying only on the clock. A pharmacist can advise on adherence, while changes to the prescribed schedule should be agreed with the prescriber.

Taking Actoplus Met With Meals

Actoplus Met should be taken with food. Food can delay and reduce metformin absorption, but taking metformin with a meal generally improves tolerability and can reduce nausea, abdominal discomfort, and diarrhoea, particularly near the start of treatment. A bowl of porridge, a cooked breakfast, or a regular evening meal can all provide a practical anchor for the prescribed schedule. Tea and coffee do not have a specific established interaction with this combination when consumed in ordinary amounts. Alcohol requires more care: excessive intake increases the risk of metformin-associated lactic acidosis and can make blood glucose harder to manage. Anyone who drinks heavily or has episodes of binge drinking should discuss this with a pharmacist, GP, or diabetes team.

Safety Priorities and Activities to Limit

Pioglitazone can cause fluid retention, so ankle swelling, unusual breathlessness, or rapid weight gain should be reported promptly because these can indicate worsening heart function. This medicine must not be used by people with heart failure or a history of heart failure. It is also contraindicated in people with current or previous bladder cancer, uninvestigated visible blood in the urine, or liver impairment. Kidney function must be assessed because the metformin component may be unsuitable in significant renal impairment.

Visual disturbance can occur, so anyone who notices blurred or altered eyesight should take extra care before driving or using machinery until the problem has been assessed. When Actoplus Met is combined with insulin or a sulphonylurea, hypoglycaemia becomes more likely. UK drivers should know how to recognise and manage low blood glucose and follow relevant DVLA guidance. Scheduled kidney, liver, heart, and eye checks remain important. New bone pain or fractures should also be discussed with a clinician because pioglitazone has been associated with an increased fracture risk, particularly in women.

Regional Patient Perspectives and Common Challenges

What UK Patients Discuss

On Patient.info forums, HealthUnlocked communities, and condition-specific UK patient forums, discussions about combination diabetes tablets commonly focus on the convenience of managing fewer tablets, early gastrointestinal effects associated with metformin, gradual weight gain, and the need for continuing blood tests and reviews. These discussions can help people identify questions to raise with a clinician, but individual forum accounts do not establish whether Actoplus Met is suitable for another person.

Common Challenges

Recurring practical challenges include adapting to gastrointestinal effects near the start of treatment, remembering periodic kidney, liver, and heart-related monitoring, and understanding why a US brand such as Actoplus Met may be less familiar in NHS diabetes clinics than its individual ingredients. Some patients also need help finding a meal-based schedule that works with shift patterns or irregular working hours. A pharmacist can suggest adherence strategies, while persistent adverse effects or any proposed dose change require clinical review.

Local Pharmacy Availability and the UK Price Landscape

Community pharmacy chains such as Boots Pharmacy, Well Pharmacy, and Superdrug Pharmacy, together with independent community chemists, are familiar medicine-access channels across UK high streets. Appropriately registered online pharmacy services provide another channel. Availability of a specific US combination brand such as Actoplus Met may vary, and no particular high-street branch should be assumed to hold this presentation. It is sensible to check the exact brand, strength, tablet presentation, pack quantity, and current availability with the relevant pharmacy before relying on it for continued treatment.

Online Pharmacy Trends in the United Kingdom

Many UK patients use online pharmacy services for the convenience of arranging established medicine supplies from home and accessing support without an in-person queue. This can be particularly useful for people in rural parts of Scotland, Wales, or Northern Ireland, where reaching a pharmacy counter may involve a longer journey, and for people whose working hours make daytime visits difficult. Online access does not replace clinical oversight. Anyone starting Actoplus Met, changing the dose, or experiencing adverse effects still needs contact with a GP, pharmacist, or diabetes team.

Patients should check which professional regulator covers the pharmacy service they use. The General Pharmaceutical Council (GPhC) regulates pharmacists, pharmacy technicians, and registered pharmacy premises in Great Britain, while Northern Ireland has separate professional arrangements. A professional register does not establish that a particular medicine is stocked, covered by the NHS, or suitable for an individual patient.

NHS and Private Access

NHS prescribing and prescription-charge arrangements differ across the four UK nations. In England, charges may apply unless the patient qualifies for an exemption; people treated for diabetes with medicine may be eligible to apply for a medical exemption certificate, subject to the applicable NHS rules. NHS prescriptions are free in Scotland, Wales, and Northern Ireland under their respective arrangements. These general rules do not establish that the exact Actoplus Met brand or 15 mg+500 mg presentation is covered, prescribed, or routinely available through any NHS service.

Whether a metformin-and-pioglitazone combination is selected through the NHS depends on clinical assessment, local formulary arrangements, and the available authorised presentations. Private access is a separate route and does not imply NHS subsidy, reimbursement, or exemption from appropriate medical supervision.

Ingredients and How Actoplus Met Works

Each tablet combines metformin, a biguanide, with pioglitazone, a thiazolidinedione. Metformin lowers blood glucose mainly by reducing glucose production in the liver and improving insulin sensitivity. It does not directly stimulate the pancreas to release more insulin. Pioglitazone activates PPAR-gamma receptors and improves the response of fat, muscle, and liver tissue to insulin. Combining the two ingredients addresses insulin resistance and excess liver glucose production through complementary mechanisms, which is why the combination may be considered when metformin alone no longer provides adequate control.

Clinical Uses in Adults

The metformin-and-pioglitazone combination is indicated for adults with type 2 diabetes who are inadequately controlled on metformin alone or who are already taking the two ingredients separately and are suitable for a fixed-dose combination. UK diabetes care guided by National Institute for Health and Care Excellence (NICE) recommendations takes account of HbA1c, cardiovascular risk, kidney health, body weight, adverse-effect risks, and personal circumstances when additional medicines are considered. Pioglitazone is one of several possible options alongside DPP-4 inhibitors, SGLT2 inhibitors, sulphonylureas, and other treatments. Actoplus Met is not used to treat type 1 diabetes and is not a weight-loss medicine.

Food, Drink, and Medicine Interactions

Excessive alcohol intake increases the risk of lactic acidosis associated with metformin and can make low blood glucose harder to recognise or manage. Other medicines can also affect glucose control or the safety of this combination. Examples include insulin, sulphonylureas, corticosteroids, some diuretics, and medicines that can alter kidney function. Any new prescribed or over-the-counter medicine should be mentioned to the pharmacist or prescriber. Iodinated contrast agents used for some scans and major surgery may require temporary interruption of metformin-containing treatment under clinical supervision. Grapefruit juice has no well-established clinically important interaction with this combination.

Recent Evidence and Regional Insights

Current type 2 diabetes management increasingly tailors treatment to cardiovascular risk, kidney health, heart-failure risk, weight, hypoglycaemia risk, and individual preferences rather than applying one sequence to everyone. Pioglitazone-containing regimens are selected carefully because fluid retention, heart failure, fractures, weight gain, liver health, and bladder-cancer history must be considered. Newer glucose-lowering medicine classes have gained a larger role for some groups, particularly when cardiovascular or kidney outcomes are priorities. Metformin-and-pioglitazone combinations nevertheless remain relevant for selected adults who can use both ingredients safely and obtain adequate glucose control from them.

Alternative Choices Available in the UK

Patients and prescribers in the UK can consider several combination and single-ingredient options, depending on clinical goals, kidney and heart health, adverse-effect risks, and response to treatment.

OptionIngredient or combinationNotable consideration
Actoplus MetMetformin and pioglitazoneCombines two mechanisms; unsuitable with heart failure or current or previous bladder cancer
JanumetSitagliptin and metforminGenerally has less risk of weight gain and fluid retention than a pioglitazone combination
JentaduetoLinagliptin and metforminKidney function still affects whether the metformin component is suitable and how it is used
JardianceEmpagliflozin, used alone or with other glucose-lowering medicinesHas established cardiovascular and kidney indications for appropriate patients

Metformin remains a common initial medicine for type 2 diabetes in the UK, while additional treatment is selected according to the individual's clinical circumstances. These alternatives are not automatically interchangeable because ingredients, doses, contraindications, monitoring requirements, and authorised uses differ.

Regulatory and Prescription Context in the UK

Actoplus Met is a US catalogue brand of the metformin-and-pioglitazone combination. The supplied regulatory information does not confirm that this exact brand, 15 mg+500 mg strength, or tablet presentation has a UK marketing authorisation. Its formal UK prescription classification therefore cannot be confirmed from an identified UK marketing-authorisation record. A UK Summary of Product Characteristics and Patient Information Leaflet for this exact presentation also cannot be confirmed.

Our checkout does not require a prescription for this product, but that store requirement is separate from the medicine's regulatory classification in the UK. Anyone starting the combination for the first time or living with heart, liver, kidney, or bladder concerns should obtain advice from a GP or pharmacist. Suspected adverse reactions can be reported to the Medicines and Healthcare products Regulatory Agency (MHRA) through the Yellow Card Scheme.

Storage in UK Household Conditions

Actoplus Met should be stored at 20°C to 25°C, with excursions permitted from 15°C to 30°C. This range suits many UK homes for much of the year, but the tablets still need protection from unsuitable household conditions. Bathroom cabinets can become damp, while cupboards beside a cooker, kettle, radiator, or other heat source may become too warm. During a summer heatwave, or inside a conservatory or parked car, temperatures can rise above the permitted range. Keep the tablets in a dry place away from direct sunlight, excessive moisture, and heat, and retain the original packaging unless a pharmacist advises otherwise.

Delivery Availability Across the UK

We offer delivery to UK addresses using two configured options. Express delivery includes tracking and has an estimated delivery time of 4 to 7 days. Standard delivery does not include tracking and has an estimated delivery time of 14 to 21 days. Free delivery applies to Express baskets over £300 and Standard baskets over £200. These times are estimates rather than guarantees.

Approximate delivery times across the United Kingdom

CityExpressStandard
Derby≈ 6 days≈ 17 days
Liverpool≈ 7 days≈ 14 days
Plymouth≈ 4 days≈ 16 days
Newcastle upon Tyne≈ 7 days≈ 20 days
Nottingham≈ 4 days≈ 17 days
These estimates are based on our experience with previous deliveries and are not guaranteed delivery dates.

The table provides representative estimates for selected UK destinations. Customers should allow enough time for dispatch and delivery before their existing supply runs low, particularly when weekends, public holidays, or local transport disruption may affect the journey.

Actoplus Met: A Regional Summary

For UK adults already established on a suitable metformin-and-pioglitazone regimen, Actoplus Met provides both ingredients in one oral tablet. Suitability depends on heart, liver, kidney, and bladder health, while continuing HbA1c and safety monitoring remains important. The exact Actoplus Met brand and 15 mg+500 mg presentation should not be assumed to have the same UK regulatory status or availability as other metformin-and-pioglitazone products. Alongside NHS and community-pharmacy routes, our online service provides another access option for customers maintaining an established diabetes routine.

Medically reviewed by
Emma Garcia
Endocrinologist and diabetologist
Updated 11 August 2026

Product specifications

Active ingredientPioglitazone and metformin
Drug classAntidiabetic combination (thiazolidinedione and biguanide)
Dosage formTablet
Available strengths15 mg/500 mg
RouteOral
StorageStore at 25 °C; excursions permitted to 15 °C to 30 °C. Keep the container tightly closed and protect from moisture and humidity.
ATC codeA10BD05

Regulatory information

United Kingdom: medicine status
UK marketing authorisationActoplus Met is a US catalogue brand, and the supplied information does not establish that this exact brand, strength or tablet presentation has a UK marketing authorisation.
Prescription classificationThe prescription classification of this exact Actoplus Met presentation in the UK cannot be confirmed without a UK marketing-authorisation record.
UK product informationA UK Summary of Product Characteristics and Patient Information Leaflet for this exact Actoplus Met presentation cannot be confirmed from the supplied UK regulatory sources.
Suspected side-effect reportingSuspected adverse reactions to medicines can be reported to the MHRA through the Yellow Card Scheme.

More information